High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab
暂无分享,去创建一个
G. Specchia | V. Liso | R. Ricco | D. Pastore | A. Napoli | M. Delia | A. Giordano | T. Perrone | C. De Risi | P. Curci | F. Gaudio | A. Spina